Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Blood infrastructure problems contribute to ASD

July 17, 2020

Sage Therapeutics describes GABA-A receptor modulators

July 16, 2020

Intra-Cellular Therapies identifies 5-HT2A, mu-opioid, dopamine D1 and D2 receptor ligands

July 16, 2020

Discovery of PQR-626, a potent and brain-penetrant mTOR inhibitor

July 16, 2020

RNA editing restores Rett protein

July 16, 2020

Down syndrome organoids give insights into Alzheimer's disease

July 15, 2020

CDK-like kinase plays role in sensing pain

July 15, 2020

First patient dosed in OLE/switch study of FT-218 in narcolepsy

July 14, 2020

INmune Bio reports interim phase Ib data on XPro-1595 in Alzheimer's disease

July 14, 2020

BAN-2401 to be evaluated in new phase III AHEAD 3-45 program

July 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...